University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Tenecteplase injection

Hospital use only

Status: Green Terbutaline nebulised

As an alternative to salbutamol nebules if salbutamol is in short supply

Status: Red Terlipressin injection

Hospital use only

Status: Amber Testosterone gel

Use in women with low libido approved by APC (unlicensed). Specialist to initiate and issue first supply.

Status: Red Testosterone implant

Hospital only - menopausal clinic

Status: Green Tetracaine (Amethocaine)  (Ametop®)

Paediatrics only

Status: Red Tetracaine hydrochloride Minims® amethocaine hydrochloride

For hospital use only

Status: Red Tezacaftor and ivacaftor (Symkevi®)

NHSE commissioning statement

Status: Red Thalidomide

GAVE in renal disease

Status: Green Theophylline (Uniphyllin continus)

Please refer to the current British National Formulary for advice on monitoring plasma-theophylline level. Theophylline levels may rise when patient stops smoking.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top